Education
About Us
Working with TipRanks
Follow Us
Nova Leap Health Corp (TSE:NLH)
:NLH
Total Valuation
Nova Leap Health has a market cap or net worth of C$23.57M. The enterprise value is C$17.02M.
Market CapC$23.57M
Enterprise ValueC$17.02M
Share Statistics
Nova Leap Health has 87,314,255 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding87,314,255
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nova Leap Health’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 3.16%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)3.16%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover1.15
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nova Leap Health is 11.92. Nova Leap Health’s PEG ratio is 0.11.
PE Ratio11.92
PS Ratio0.00
PB Ratio0.77
Price to Fair Value0.90
Price to FCF15.08
Price to Operating Cash Flow14.03
PEG Ratio0.11
Income Statement
In the last 12 months, Nova Leap Health had revenue of 25.76M and earned 1.38M in profits. Earnings per share was 0.02.
Revenue25.76M
Gross Profit9.89M
Operating Income863.71K
Pretax Income1.81M
Net Income1.38M
EBITDA2.50M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 1.39M and capital expenditures -25.00K, giving a free cash flow of 1.36M billion.
Operating Cash Flow1.39M
Free Cash Flow1.36M
Free Cash Flow per Share0.02
Dividends & Yields
Nova Leap Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change-15.62%
50-Day Moving Average0.26
200-Day Moving Average0.26
Relative Strength Index (RSI)52.35
Average Volume (3m)27.58K
Important Dates
Nova Leap Health upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Nova Leap Health as a current ratio of 1.06, with Debt / Equity ratio of 21.23%
Current Ratio1.06
Quick Ratio1.06
Debt to Market Cap0.09
Net Debt to EBITDA0.45
Interest Coverage Ratio8.08
Taxes
In the past 12 months, Nova Leap Health has paid 433.54K in taxes.
Income Tax433.54K
Effective Tax Rate0.24
Enterprise Valuation
Nova Leap Health EV to EBITDA ratio is 7.01, with an EV/FCF ratio of 12.87.
EV to Sales0.68
EV to EBITDA7.01
EV to Free Cash Flow12.87
EV to Operating Cash Flow12.64
Balance Sheet
Nova Leap Health has C$1.40M in cash and marketable securities with $2.53M in debt, giving a net cash position of C$1.12M billion.
Cash & Marketable SecuritiesC$1.40M
Total Debt$2.53M
Net CashC$1.12M
Net Cash Per ShareC$0.01
Tangible Book Value Per ShareC$0.02
Margins
Gross margin is 35.37%, with operating margin of 3.35%, and net profit margin of 5.35%.
Gross Margin35.37%
Operating Margin3.35%
Pretax Margin7.03%
Net Profit Margin5.35%
EBITDA Margin9.71%
EBIT Margin7.45%
Analyst Forecast
The average price target for Nova Leap Health is C$0.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.60
Price Target Upside122.22% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast4.09%
EPS Growth Forecast―